A study to investigate the effect of enzyme inhibition on the bodily processing of RO6953958 in healthy participants
A non-randomized, open-label, single-sequence, two-period phase I study to investigate the effect of CYP3A inhibition on the pharmacokinetics of RO6953958 in healthy participants
Neurodevelopmental Disorder
For the latest version of this information please go to www.forpatients.roche.com